DiaSorin stock gains 1.15 percent near its 52-week high
Published on 09/24/2026 at 13:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
DiaSorin stock (ISIN not shown) was trading at EUR 79.02 on Euronext Milan on September 24, 2026, at 12:51 p.m. CEST, up 1.15 percent during the session. The price stood 1.69 percent below the 52-week high of EUR 80.38, putting the diagnostic group close to its yearly peak.
Barclays raises target to EUR 70
Teleborsa reported on September 8, 2026, that Barclays raised its DiaSorin target price from EUR 60 to EUR 70 and retained an Underweight rating. The revised target remains below the September 24 price, making the valuation gap part of the current market debate.
The target change is notable because it combines a EUR 10 increase with a cautious rating. For investors, that split points to a more constructive valuation view without removing execution concerns.
Index change reshapes the backdrop
DiaSorin moved out of the FTSE MIB when Technoprobe entered the index on September 21, 2026. Borsa Italiana said the change placed DiaSorin in the FTSE Italia Mid Cap index, while Technoprobe took its position among the 40 blue-chip companies.
The index switch provides a concrete explanation for the stock's trading context. DiaSorin's market capitalization was EUR 3,907,770,529 on September 24, 2026, while volume reached 74,193 shares by the quoted intraday snapshot.
Stock tests the yearly high
DiaSorin's 52-week range was EUR 52.34 to EUR 80.38 on September 24, 2026. At EUR 79.02, the stock was EUR 1.36 below the upper boundary, leaving the distance to the annual high smaller than the EUR 26.68 span from the low to the current price.
The price and index position now frame the investment discussion. Barclays' EUR 70 target sits EUR 9.02 below the intraday quote, while the market capitalization and proximity to the annual high show why the rating change and index move matter for valuation-sensitive investors.
DiaSorin stock remains near its high
DiaSorin stock was trading at EUR 79.02 on Euronext Milan on September 24, 2026, with a 1.15 percent intraday gain. The quote was 1.69 percent below the 52-week high of EUR 80.38.
DiaSorin market snapshot
- Company: DiaSorin S.p.A.
- Ticker: DIA.MI
- Trading venue: Euronext Milan
- Price: EUR 79.02, September 24, 2026, 12:51 p.m. CEST
- Market capitalization: EUR 3,907,770,529 as of September 24, 2026
- 52-week range: EUR 52.34-80.38 as of September 24, 2026
- Sector / Industry: Healthcare / Medical Diagnostics and Research
- Index membership: FTSE Italia Mid Cap
